Senseonics and Clovis Oncology gain ahead of inclusion in Russell Indexes

JuSun/iStock via Getty Images

  • After a six-day losing streak that led the company to lose nearly a fifth of its value, the maker of Eversense glucose monitoring system Senseonics Holdings (SENS +5.3%
    ) is on track to record its fourth straight session of…

Click here to view the original article.